PL378179A1 - Sposób wytwarzania podstawionych pochodnych imidazolu i związki pośrednie stosowane w sposobie - Google Patents

Sposób wytwarzania podstawionych pochodnych imidazolu i związki pośrednie stosowane w sposobie

Info

Publication number
PL378179A1
PL378179A1 PL378179A PL37817904A PL378179A1 PL 378179 A1 PL378179 A1 PL 378179A1 PL 378179 A PL378179 A PL 378179A PL 37817904 A PL37817904 A PL 37817904A PL 378179 A1 PL378179 A1 PL 378179A1
Authority
PL
Poland
Prior art keywords
sub
imidazole derivatives
substituted imidazole
preparing substituted
intermediates used
Prior art date
Application number
PL378179A
Other languages
English (en)
Other versions
PL213564B1 (pl
Inventor
Päivi Juujärvi
Seppo Parhi
Jaana Karjalainen
Original Assignee
Oy Juvantia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oy Juvantia Pharma Ltd filed Critical Oy Juvantia Pharma Ltd
Publication of PL378179A1 publication Critical patent/PL378179A1/pl
Publication of PL213564B1 publication Critical patent/PL213564B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL378179A 2003-01-08 2004-01-08 Sposób wytwarzania podstawionych pochodnych imidazolu i zwiazki posrednie stosowane w sposobie PL213564B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20030026A FI116292B (fi) 2003-01-08 2003-01-08 Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita

Publications (2)

Publication Number Publication Date
PL378179A1 true PL378179A1 (pl) 2006-03-06
PL213564B1 PL213564B1 (pl) 2013-03-29

Family

ID=8565279

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378179A PL213564B1 (pl) 2003-01-08 2004-01-08 Sposób wytwarzania podstawionych pochodnych imidazolu i zwiazki posrednie stosowane w sposobie

Country Status (21)

Country Link
US (1) US7223871B2 (pl)
EP (1) EP1581504B1 (pl)
JP (1) JP4592680B2 (pl)
KR (1) KR101079065B1 (pl)
CN (1) CN100339368C (pl)
AT (1) ATE425972T1 (pl)
AU (1) AU2004203941B2 (pl)
BR (1) BRPI0406676A (pl)
CA (1) CA2511969C (pl)
DE (1) DE602004020050D1 (pl)
DK (1) DK1581504T3 (pl)
ES (1) ES2322463T3 (pl)
FI (1) FI116292B (pl)
IL (1) IL168452A (pl)
MX (1) MXPA05007217A (pl)
NO (1) NO330965B1 (pl)
NZ (1) NZ539831A (pl)
PL (1) PL213564B1 (pl)
PT (1) PT1581504E (pl)
RU (1) RU2329253C2 (pl)
WO (1) WO2004063168A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008003553A1 (es) * 2007-12-05 2009-11-27 Grindeks Jsc Proceso para preparar atipamezol o clorhidrato de 5-(2-etil-2,3-dihidro-1h-inden-2-il)-1h-imidazol: y loa compuestos intermediarios considerados en el proceso
EP2456749B1 (en) 2009-07-24 2016-03-30 DSM Pharma Chemicals Regensburg GmbH Indane derivatives for use as intermediates
WO2011014613A2 (en) * 2009-07-31 2011-02-03 Dr. Reddy's Laboratories Ltd. Preparation of fipamezole
EP2502917A1 (en) * 2011-03-17 2012-09-26 Santhera Pharmaceuticals (Schweiz) AG Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole
US12416024B2 (en) 2018-03-29 2025-09-16 Transworld Technologies Inc. Biologically enhanced oil recovery methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI833794A0 (fi) * 1983-10-18 1983-10-18 Farmos Oy Substituerade 2-merkapto-imidazoler
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
AU7040500A (en) 1999-09-06 2001-04-10 Lg Chem Investment Ltd. Process for preparing a 1-substituted 5-hydroxymethyl imidazole
US7091232B2 (en) 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Also Published As

Publication number Publication date
FI116292B (fi) 2005-10-31
AU2004203941A1 (en) 2004-07-29
IL168452A (en) 2009-07-20
KR20050091065A (ko) 2005-09-14
AU2004203941B2 (en) 2009-08-06
PL213564B1 (pl) 2013-03-29
RU2329253C2 (ru) 2008-07-20
EP1581504A1 (en) 2005-10-05
NO330965B1 (no) 2011-08-29
PT1581504E (pt) 2009-05-26
JP4592680B2 (ja) 2010-12-01
CA2511969C (en) 2011-10-11
DK1581504T3 (da) 2009-06-29
US7223871B2 (en) 2007-05-29
JP2006515349A (ja) 2006-05-25
CN100339368C (zh) 2007-09-26
BRPI0406676A (pt) 2005-12-20
FI20030026L (fi) 2004-07-09
CN1723202A (zh) 2006-01-18
RU2005125044A (ru) 2006-01-20
ES2322463T3 (es) 2009-06-22
US20060025465A1 (en) 2006-02-02
NZ539831A (en) 2007-11-30
ATE425972T1 (de) 2009-04-15
MXPA05007217A (es) 2005-09-12
FI20030026A0 (fi) 2003-01-08
CA2511969A1 (en) 2004-07-29
EP1581504B1 (en) 2009-03-18
NO20053712L (no) 2005-08-01
KR101079065B1 (ko) 2011-11-02
WO2004063168A1 (en) 2004-07-29
DE602004020050D1 (de) 2009-04-30

Similar Documents

Publication Publication Date Title
PL2428519T3 (pl) Kompozycja do wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich
WO2007041167A3 (en) Process for production of delta-9-tetrahydrocannabinol
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
UA101482C2 (ru) Способ получения 2'-дезокси-5-азацитидина (децитабина)
EP1279665A3 (en) A process for the preparation of perindopril, its analogous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds
CA2436848A1 (en) Coupling process and intermediates useful for preparing cephalosporins
IL159814A0 (en) Process for the production of beraprost an its salts
MY139404A (en) Preparation process of some halogeno-substituted monosulfides and their hydroxymonosulfide or isothiouronium bromide equivalents as intermediates
WO2005058812A3 (en) Prostaglandin synthesis
Huang et al. Synthesis of 2-(benzoylmethylene) imidazolidines and-hexahydropyrimidines by condensation of ethyl benzoylacetimidates with 1, 2-ethanediamine or 1, 3-propandiamine, and some addition reactions
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
EP1439165A4 (en) INHIBITOR OF THE BIOSYNTHESIS OF ABSIC ACID
CA2336380A1 (en) Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
AU2002218422A1 (en) New desloratadine salts, process for their synthesis and pharmaceutical compositions thereof
MEP1708A (xx) Postupak proizvodnje thip-a
MXPA03011647A (es) Procedimiento de resolucion para el acido ( r ) - (-) - 2-hidroxi - 2- (2 - clorofenil) acetico.
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
WO2004029006A3 (en) Process for the preparation of fluorohaloalkanes
HRP20030854A2 (en) Process for preparing fluconazole and its crystal modifications
AU2003231926A1 (en) NOVEL PROCESS FOR STEREOSELECTIVE REDUCTION OF ss-KETOESTERS
MXPA05011859A (es) Nuevo compuesto intermedio para la preparacion de imidazopiridinas terapeuticamente activas.
WO2005046854A3 (en) A process for the preparation of diphenylmethylsulfinyl derivatives
NO20055925L (no) Ny fremgangsmate for fremstilling av melagatran
DE60127979D1 (de) Verfahren zur herstellung von 3,5-bisalkylphenolen

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20140108